About 30 results found for searched term "Gly-Asp" (0.045 seconds)
Cat.No. | Name | Target |
---|---|---|
M2976 | RGD | Integrin |
Arg-Gly-Asp | ||
RGD (Arg-Gly-Asp) Peptides is a cell adhesion motif which can mimic cell adhesion proteins and bind to integrins. | ||
M5619 | Eptifibatide | Integrin |
MPA-HAR-Gly-Asp-Trp-Pro-Cys-NH2; {MPA}{HAR}GDWPC-NH2 | ||
Eptifibatide is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. | ||
M10209 | Cyclo(-RGDfK) | Integrin |
Cyclo(-Arg-Gly-Asp-D-Phe-Lys) | ||
Cyclo (-RGDfK) is an effective and specific αvβ3 integrin inhibitor. | ||
M13751 | Arg-Gly-Asp-Ser | Integrin |
RGDS peptide; Fibronectin tetrapeptide | ||
Arg-Gly-Asp-Ser is an integrin binding sequence that inhibits integrin receptor function. Arg-Gly-Asp-Ser directly and specifically bind pro-caspase-8, pro-caspase-9 and pro-caspase-3, while it does not bind pro-caspase-1. | ||
M19085 | Glyasperin A | Others |
Glyasperin A | ||
M20860 | Eptifibatide Acetate | Others |
Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2 | ||
Eptifibatide Acetate is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue. A disulfide bridge forms between mercaptopropionyl and cysteine. Eptifibatide prevents platelet aggregation. One study shows the inhibition of platelet glycoprotein IIb/IIIa in acute coronary syndromes. | ||
M21551 | Cyclo[Arg-Gly-Asp-D-Phe-Lys(Cys)] | Peptides |
Cyclo[Arg-Gly-Asp-D-Phe-Lys(Cys)] is a peptide that binds to integrins, a type of receptor protein on the surface of cells. | ||
M38682 | Glyasperin D | Antibiotic |
Glyasperin D is a flavonoid isolated from Glycyrrhiza uralensis, and possesses weaker anti-Helicobacter pylori activity. | ||
M39960 | Dehydroglyasperin C | Others |
Dehydroglyasperin C, a isoflavone, is a potent NAD(P)H:oxidoquinone reductase (NQO1) and phase 2 enzyme inducer. Dehydroglyasperin C has antioxidant, neuroprotective, cancer chemopreventive, and anti-inflammatory activities. | ||
M40054 | Glyasperin C | Others |
Glyasperin C is a potent and reversible noncompetitive inhibitor of neuraminidase with an IC50 of 20% at 200 μM. Glyasperin C is a polyphenol isolated from the roots of Glycyrrhiza uralensis. | ||
M42282 | Dehydroglyasperin D | Aldose Reductase |
Dehydroglyasperin D inhibits rat and human Aldose Reductase (AR) (IC50: 62.4 μM and 176.2 μM respectively). | ||
M44176 | Glyasperin F | Others |
Glyasperin F | ||
M50903 | H-Gly-Asp-Gly-OH | Others |
H-Gly-Asp-Gly-OH is a polypeptide that can be found by peptide screening. | ||
M51023 | Arg-Gly-Asp-Ser-Pro | Others |
Arg-Gly-Asp-Ser-Pro is a polypeptide that can be found by peptide screening. | ||
M51173 | H-Gly-Arg-Gly-Asp-Ser-NH2 | Others |
Gly-Arg-Gly-Asp-Ser-NH2 is a pentapeptide with no N-terminal modification. | ||
M51304 | Biotinyl-(εAhx)-Gly-Arg-Gly-Asp-Ser | Others |
Biotinyl-(εAhx)-Gly-Arg-Gly-Asp-Ser is a polypeptide that can be found by peptide screening. | ||
M51307 | Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) | Others |
Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) (Azido-c(RGDyK)) is a polypeptide composed of arginine, glycine, aspartic acid, and tyrosine that can be used for Synthesis of [18F]FPyKYNE-c(RGDyK). | ||
M51665 | Arg-Gly-Asp-Cys | Others |
Arg-Gly-Asp-Cys is the binding motif of fibronectin to cell adhesion molecules, and can inhibit platelet aggregation and fibrinogen binding. | ||
M51669 | Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge:cys1-cys10) | Others |
Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge:cys1-cys10), a decapeptide containing a cyclic RGD active sequence, is an Integrin αIIbβ3 antagonist that inhibits platelet and Adhesion of proMMP-13. | ||
M51738 | Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) | Others |
Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) (c(RGDfE)) is a cyclic RGD peptide that serves as a conjugated multifunctional nanodrug delivery system to target Gemcitabine to pancreatic cancer cells. | ||
M51748 | Gly-Asp | Amino Acid Derivatives |
Gly-Asp is a Glycine derivative. | ||
M53328 | Lys-Gln-Ala-Gly-Asp-Val | Integrin |
Lys-Gln-Ala-Gly-Asp-Val (KQAGDV) is the six most carboxyl-terminal amino acids in the fibrinogen γ-chain sequence. | ||
M53331 | Cyclo(Ala-Arg-Gly-Asp-Mamb) | Integrin |
Cyclo(Ala-Arg-Gly-Asp-Mamb) is a selective RGD peptide antagonist and has the potential for Pulmonary arterial hypertension Research. | ||
M53332 | Cyclo(Arg-Gly-Asp-D-Phe-Val) | Integrin |
Cyclo(Arg-Gly-Asp-D-Phe-Val) is an integrin αvβ3 inhibitor. | ||
M53333 | Cyclo(Gly-Arg-Gly-Asp-Ser-Pro) | Integrin |
Cyclo(Gly-Arg-Gly-Asp-Ser-Pro) (c(GRGDSP)) is an RGD-containing inhibitory peptide. | ||
M53334 | FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro | Integrin |
FITC-Ahx Gly Arg Gly Asp Ser Pro is a GRGDSP coupled to FITC. | ||
M53340 | Gly-Arg-Gly-Asp-Ser TFA | Integrin |
Gly-Arg-Gly-Asp-Ser (TFA) is a pentapeptide that forms the cell-binding domain of a glycoprotein, osteopontin. | ||
M53864 | Arg-Gly-Asp-Cys TFA | Others |
Arg-Gly-Asp-Cys TFA is the binding motif of fibronectin to cell adhesion molecules. | ||
M53932 | Gly-Arg-Gly-Asp-Ser | Integrin |
Gly-Arg-Gly-Asp-Ser is a pentapeptide that forms the cell-binding domain of a glycoprotein, osteopontin. | ||
M54037 | Cyclo(Arg-Gly-Asp-D-Phe-Cys) | Integrin |
Cyclo(Arg-Gly-Asp-D-Phe-Cys) (Cyclo RGDfC), a cyclic RGD peptide which has high affinity to αvβ3, can disrupt cell integrin interactions. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.